{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:29:44Z","timestamp":1788316184572,"version":"build-2803163510"},"reference-count":19,"publisher":"American Diabetes Association","issue":"1","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>We have previously shown that chronic inflammation results in immunosuppression associated with CD247 downregulation in T lymphocytes. Type 2 diabetes mellitus (T2DM) is known to be associated with chronic inflammation. We therefore sought to examine CD247 expression levels in patients with T2DM and to assess whether it can serve as a diagnostic and prognostic biomarker for disease complications and outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Peripheral blood samples from 75 T2DM patients and 40 healthy control subjects were collected and analyzed for the expression level of CD247 in T lymphocytes. Subjects with T2DM underwent a medical interview with physical examination and were followed for an additional average of 19.2 \u00b1 0.9 months to determine the occurrence of major adverse disease end points. The relationship between the level of CD247 expression and disease status at the time of blood draw and the ability of the marker to identify future complications was evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We observed a significant reduction in CD247 expression levels in T lymphocytes of T2DM patients when compared with healthy volunteers. CD247 downregulation was associated with disease severity, complications, and the occurrence of future cardiovascular events, suggesting its potential use not only as a diagnostic but also as a prognostic biomarker.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Our results suggest the use of CD247 as a biomarker in diabetic patients for evaluating the state of chronic inflammation that contributes to morbidity and mortality in this disease and for the prediction of future cardiovascular events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc14-1544","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T04:25:51Z","timestamp":1415075151000},"page":"113-118","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":25,"title":["CD247, a Novel T Cell\u2013Derived Diagnostic and Prognostic Biomarker for Detecting Disease Progression and Severity in Patients With Type 2 Diabetes"],"prefix":"10.2337","volume":"38","author":[{"given":"Roy","family":"Eldor","sequence":"first","affiliation":[{"name":"Diabetes Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Klieger","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel"},{"name":"Improdia Ltd., Herzliya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Sade-Feldman","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Vaknin","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Varfolomeev","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camil","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Department of Statistics and Operations Research, Tel-Aviv University, Ramat Aviv, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Baniyash","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2014,11,3]]},"reference":[{"key":"2022031301553669100_B1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diabet.2010.07.001","article-title":"Diabetes and inflammation: fundamental aspects and clinical implications","volume":"36","author":"Garcia","year":"2010","journal-title":"Diabetes Metab"},{"key":"2022031301553669100_B2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cca.2009.07.003","article-title":"Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus","volume":"408","author":"Jin","year":"2009","journal-title":"Clin Chim Acta"},{"key":"2022031301553669100_B3","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2337\/dc06-2417","article-title":"Type 2 diabetes and pneumonia outcomes: a population-based cohort study","volume":"30","author":"Kornum","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031301553669100_B4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2006.00033.x","article-title":"C-reactive protein (CRP)-lowering agents","volume":"24","author":"Prasad","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"2022031301553669100_B5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2007-948213","article-title":"Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines","volume":"115","author":"Abrahamian","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2022031301553669100_B6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.endonu.2011.01.006","article-title":"Microvascular complications and risk factors in patients with type 2 diabetes","volume":"58","author":"Del Ca\u00f1izo G\u00f3mez","year":"2011","journal-title":"Endocrinol Nutr"},{"key":"2022031301553669100_B7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(03)00408-6","article-title":"Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus","volume":"42","author":"Navarro","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2022031301553669100_B8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10753-013-9746-4","article-title":"Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control","volume":"37","author":"Fronczyk","year":"2014","journal-title":"Inflammation"},{"key":"2022031301553669100_B9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri1434","article-title":"TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response","volume":"4","author":"Baniyash","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2022031301553669100_B10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0092-8674(91)90314-O","article-title":"The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways","volume":"64","author":"Irving","year":"1991","journal-title":"Cell"},{"key":"2022031301553669100_B11","first-page":"313","article-title":"Signal transduction by the T cell antigen receptor","volume":"3","author":"Weiss","year":"1991","journal-title":"Semin Immunol"},{"key":"2022031301553669100_B12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/ni975","article-title":"Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function","volume":"4","author":"Bronstein-Sitton","year":"2003","journal-title":"Nat Immunol"},{"key":"2022031301553669100_B13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365521.2013.863966","article-title":"Expression pattern of T-helper 17 cell signaling pathway and mucosal inflammation in celiac disease","volume":"49","author":"Lahdenper\u00e4","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"2022031301553669100_B14","doi-asserted-by":"crossref","first-page":"e71629","DOI":"10.1371\/journal.pone.0071629","article-title":"Down regulation of T cell receptor expression in COPD pulmonary CD8 cells","volume":"8","author":"Grundy","year":"2013","journal-title":"PLoS ONE"},{"key":"2022031301553669100_B15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4049\/jimmunol.180.2.1060","article-title":"Polymorphisms in the CD3Z gene influence TCRzeta expression in systemic lupus erythematosus patients and healthy controls","volume":"180","author":"Gorman","year":"2008","journal-title":"J Immunol"},{"key":"2022031301553669100_B16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2014.1873","article-title":"Glycated hemoglobin measurement and prediction of cardiovascular disease","volume":"311","author":"Di Angelantonio","year":"2014","journal-title":"JAMA"},{"key":"2022031301553669100_B17","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031301553669100_B18","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031301553669100_B19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archinte.165.2.221","article-title":"Fluctuating inflammatory markers in patients with stable ischemic heart disease","volume":"165","author":"Bogaty","year":"2005","journal-title":"Arch Intern Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/38\/1\/113\/622517\/113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/38\/1\/113\/622517\/113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T06:00:28Z","timestamp":1647151228000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/38\/1\/113\/37816\/CD247-a-Novel-T-Cell-Derived-Diagnostic-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,3]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,11,3]]},"published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc14-1544","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,3]]}}}